Human acid sphingomyelinase structures provide insight to molecular basis of Niemann-Pick disease.
Zhou, Y.F., Metcalf, M.C., Garman, S.C., Edmunds, T., Qiu, H., Wei, R.R.(2016) Nat Commun 7: 13082-13082
- PubMed: 27725636 
- DOI: 10.1038/ncomms13082
- Primary Citation of Related Structures:  
5I81, 5I85, 5I8R - PubMed Abstract: 
Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to ceramide and phosphocholine, essential components of myelin in neurons. Genetic alterations in ASM lead to ASM deficiency (ASMD) and have been linked to Niemann-Pick disease types A and B. Olipudase alfa, a recombinant form of human ASM, is being developed as enzyme replacement therapy to treat the non-neurological manifestations of ASMD ...